← Open Payments lookup

KAYLEE ANKROM: Open Payments

NPI 1104474741 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$319 in 18 payments from 11 companies in 2025. Trend: 2023 $529 · 2024 $401 · 2025 $319

Food & beverage: $319
CompanyPaymentsAmount
Lilly USA, LLC6$101
Vanda Pharmaceuticals Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Dexcom, Inc.1$19
Astellas Pharma US Inc1$19
GlaxoSmithKline, LLC.1$19
Otsuka America Pharmaceutical, Inc.1$16
Exact Sciences Corporation1$16
AstraZeneca Pharmaceuticals LP1$15
Merck Sharp & Dohme LLC1$15

Products named: MOUNJARO, FANAPT, CAPLYTA, Dexcom G6 Transmitter, Veozah, SHINGRIX, KISUNLA, REXULTI.

Industry payments across MO — which companies pay providers there.